Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $48.1B |
| FY2017, ended Dec 31, 2017 | $52.8B |
| FY2018, ended Dec 31, 2018 | $57.1B |
| FY2019, ended Dec 31, 2019 | $69.4B |
| FY2020, ended Dec 31, 2020 | $60.6B |
| FY2021, ended Dec 31, 2021 | $63.7B |
| FY2022, ended Dec 31, 2022 | $51.2B |
| FY2023, ended Dec 31, 2023 | $39.4B |
| FY2024, ended Dec 31, 2024 | $45.9B |
| FY2025, ended Dec 31, 2025 | $51.5B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $54.4B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $11.7B |
| FY2017, ended Dec 31, 2017 | $12.6B |
| FY2018, ended Dec 31, 2018 | $11.2B |
| FY2019, ended Dec 31, 2019 | $14.4B |
| FY2020, ended Dec 31, 2020 | $14.2B |
| FY2021, ended Dec 31, 2021 | $11.7B |
| FY2022, ended Dec 31, 2022 | $14.6B |
| FY2023, ended Dec 31, 2023 | $14.4B |
| FY2024, ended Dec 31, 2024 | $14.5B |
| FY2025, ended Dec 31, 2025 | $16.5B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $17.5B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.12B | −$1.93B |
| FY2017, ended Dec 31, 2017 | $3.00B | −$1.00B |
| FY2018, ended Dec 31, 2018 | $2.45B | $519M |
| FY2019, ended Dec 31, 2019 | $1.36B | $224M |
| FY2020, ended Dec 31, 2020 | −$401M | — |
| FY2021, ended Dec 31, 2021 | $3.40B | — |
| FY2022, ended Dec 31, 2022 | $1.19B | — |
| FY2023, ended Dec 31, 2023 | $1.96B | — |
| FY2024, ended Dec 31, 2024 | $2.03B | — |
| FY2025, ended Dec 31, 2025 | $3.00B | — |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $2.95B | — |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $261M |
| FY2017, ended Dec 31, 2017 | $120M |
| FY2018, ended Dec 31, 2018 | $268M |
| FY2019, ended Dec 31, 2019 | $135M |
| FY2020, ended Dec 31, 2020 | $172M |
| FY2021, ended Dec 31, 2021 | $283M |
| FY2022, ended Dec 31, 2022 | $119M |
| FY2023, ended Dec 31, 2023 | $184M |
| FY2024, ended Dec 31, 2024 | $310M |
| FY2025, ended Dec 31, 2025 | $250M |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $351M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $35.3B |
| FY2017, ended Dec 31, 2017 | $37.6B |
| FY2018, ended Dec 31, 2018 | $35.4B |
| FY2019, ended Dec 31, 2019 | $31.2B |
| FY2020, ended Dec 31, 2020 | $36.4B |
| FY2021, ended Dec 31, 2021 | $40.0B |
| FY2022, ended Dec 31, 2022 | $45.3B |
| FY2023, ended Dec 31, 2023 | $44.2B |
| FY2024, ended Dec 31, 2024 | $41.8B |
| FY2025, ended Dec 31, 2025 | $48.8B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $51.8B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 40.0% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 628M |
| FY2017, ended Dec 31, 2017 | 652M |
| FY2018, ended Dec 31, 2018 | 799M |
| FY2019, ended Dec 31, 2019 | 838M |
| FY2020, ended Dec 31, 2020 | 806M |
| FY2021, ended Dec 31, 2021 | 810M |
| FY2022, ended Dec 31, 2022 | 835M |
| FY2023, ended Dec 31, 2023 | 837M |
| FY2024, ended Dec 31, 2024 | 852M |
| FY2025, ended Dec 31, 2025 | 879M |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | 879M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash | Used in acquisitions |
|---|---|---|---|---|
| FY2016, ended Dec 31, 2016 | — | $33.0M | $2.15B | — |
| FY2017, ended Dec 31, 2017 | — | $45.0M | $1.30B | — |
| FY2018, ended Dec 31, 2018 | — | $48.0M | $2.46B | — |
| FY2019, ended Dec 31, 2019 | — | $46.0M | $2.52B | $6.82B |
| FY2020, ended Dec 31, 2020 | $3.08B | $64.0M | $159M | — |
| FY2021, ended Dec 31, 2021 | — | $42.0M | $192M | — |
| FY2022, ended Dec 31, 2022 | — | $36.0M | $1.87B | — |
| FY2023, ended Dec 31, 2023 | — | $44.0M | $94.0M | — |
| FY2024, ended Dec 31, 2024 | — | $53.0M | $732M | — |
| FY2025, ended Dec 31, 2025 | — | $46.0M | $1.49B | — |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | — | — | $1.49B | — |
Valuation
At current price- Market Cap
- $57.5B
- P/E
- 19.5×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 3.3×
- Price / Book
- 2.0×
- EV / EBITDA
- 15.5×
Growth
Trailing 12 months- Revenue (TTM)
- $17.5B
- Revenue Growth YoY
- 17.5%
- Revenue CAGR 3Y
- 4.3%
- Revenue CAGR 5Y
- 3.1%
- EPS Growth YoY
- 27.7%
- Net Income Growth YoY
- 28.7%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 26.1%
- Net Margin
- 16.9%
- FCF Margin
- —. Free cash flow / revenue
- Return on Equity
- 10.5%
Earnings
Trailing 12 months- Net Income
- $2.95B
- EPS (diluted)
- $3.37
- EBITDA
- $7.02B
- Operating Income
- $4.58B
Balance Sheet
As of Mar 31, 2026- Cash and cash equivalents
- $351M
- Total Debt
- $51.8B
- Net Debt
- $51.4B
- Total Assets
- $119B
- Total Liabilities
- $84.9B
- Shareholders' Equity
- $29.1B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $5.06B
- Capital Expenditure
- —
- Free Cash Flow
- —. Operating cash flow − capital expenditure
Dividends and risk
Last 12 months- Dividend Yield
- 4.1%
- Dividend / Share
- $2.67
- Beta (5Y)
- 0.64
Every ratio is calculated from the company’s reported figures.